Entre em contato conosco
Segunda a sexta-feira, de 8 a.m. a 5 p.m.
Our Multidisciplinary Approach
Boston Medical Center (BMC) is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. Isso pode ocorrer como parte de um distúrbio de células plasmáticas (AL) da medula óssea, como uma forma hereditária (FA), uma forma relacionada à idade (amiloidose sistêmica senil devido a ATTR) ou secundária a doenças inflamatórias ou infecciosas crônicas (AA).
In conjunction with the Boston University Chobanian & Avedisian School of Medicine, the Amyloidosis Center at BMC offers a multidisciplinary approach to diagnosis and treatment of this multi-organ disorder. Under the direction of Vaishali Sanchorawala, MD, the Center is unique in its approach, providing exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research.
Because the disease frequently involves more than one organ system, BMC offers a multispecialty evaluation for patients. This three-day outpatient evaluation is comprised of tests and consultations that help determine the amyloid type and organ system involvement. Os pacientes são orientados em cada etapa da avaliação, com médicos e enfermeiros explicando por que cada teste está sendo feito e o que os resultados significam. Uma vez concluída a avaliação, um plano de tratamento é desenvolvido.
Specialists in hematology-oncology, cardiovascular medicine, gastroenterology, kidney (renal) medicine, neurology, otolaryngology, pathology and laboratory medicine, pulmonary medicine, radiation oncology, and urology coordinate to evaluate patients and develop care plans.
Serviços de consulta médica e patológica também estão disponíveis para pacientes e médicos.
Please visit BU’s Amyloidosis Center website for more information about the different types of amyloidosis, the patient evaluation process, and consultation services.
Nossa equipe
The BMC amyloidosis clinical team is a multidisciplinary group of physicians. Cada subespecialista é um especialista em amiloide e já atendeu centenas de pacientes com amiloidose.
Vaishali Sanchorawala, MD
John L. Berk, MD
Sonia Ananthakrishnan, MD
Eric J. Burks, MD
Margaux Dockerty Martin, NP
Sophia (Sophie) Z. Grimes, MSN, RN, FNP-C
Andrea I. Havasi, MD
Shabatun J. Islam, MD
Kwan Hon Vincent Lau, MD
Caryn A. Libbey, MD
Hanni Menn-Josephy, MD
Frederick L. Ruberg, MD
Omar K. Siddiqi, MD
J. Mark Sloan, MD
Visão geral da pesquisa
Pacientes com amiloidose têm sido imensamente auxiliados por meio de avanços derivados de programas de pesquisa laboratorial e translacional coordenados por investigadores clínicos do BMC e investigadores de laboratório da Boston University Chobanian & Avedisian School of Medicine. The Amyloidosis Center at the Boston University Chobanian & Avedisian School of Medicine has been in existence since 1960, and has been responsible for many advances in the field, including some of the first randomized treatment trials, stem-cell transplant trials, trials with novel agents and small molecules, and protocols for liver and heart transplantation for selected patients.